Project Grant K23DK140602

Award Date 9/1/24
Completion Date 5/31/28
Dollars Obligated $578K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Sacramento, CA 95817, USA
Similar Awards
This $497,016 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, aims to improve perioperative health outcomes for patients with end-stage kidney disease. The key products and services to be delivered include: Evaluating the link between modifiable preoperative dialysis parameters and postoperative complications to identify optimal dialysis practices for this...
This federal Project Grant award of $344,632 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research to evaluate the impact of recent changes to the kidney allocation system in the United States. The research aims to: (1) assess whether the supply of organs is equitably distributed among U.S. transplant centers under the new 250-nautical-mile kidney...
This $518,661 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to advance the design of hemodialysis cartridges beyond the focus on urea removal. The project will test a novel parallel-plate dialyzer design that controls shear forces to potentially reduce platelet activation and clotting risks for the 548,000 Americans who rely on dialysis. The award to Vanderbilt...
This $555,034 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund the "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-FOOT-NAV)" randomized controlled trial. The primary objective is to assess the effectiveness of a comprehensive patient navigator program to improve healing rates for diabetic foot...
The University of California, San Francisco (UCSF) was awarded a $312,198 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant, which runs from July 15, 2024 to June 30, 2029, will support a research program focused on cardiovascular disease risk reduction in adolescents and young adults with kidney disease. Key objectives include elucidating patterns of cardiovascular risk, understanding...
This federal Project Grant award for $892,433.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research aimed at understanding the role of eicosanoids (bioactive lipid molecules) in the development of chronic kidney disease (CKD) and associated cardiovascular risk. The research project, led by the principal investigator at Cedars-Sinai Medical Center,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $312,088 to Sojourn Medtech LLC to develop the CANSIM simulator. The CANSIM is a smart, personalized, and dialysis-specific training device to teach critical cannulation skills to dialysis nurses and patient care technicians. The key features include: 1) dialysis-specific design, 2) realistic and low-maintenance...
The University of California, San Diego, Scripps Research Institute, and San Diego State University are collaborating on a Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $426,769 award will establish a training core to recruit and support 10 outstanding and diverse scholars annually, including at least 2 in hematology research, 2 in urology...
This federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the role of glycosphingolipids in the progression of kidney disease in obesity and diabetes. The total award amount is $830,500.00 with a start date of January 20, 2025 and a planned completion date of November 30, 2028. The key products and services to be...
The Department of Health and Human Services National Institutes of Health (NIH) awarded Duke University a $1,425,761 Project Grant under the Trans-NIH Research Support (CFDA 93.310) federal grant program. The purpose of this 3-year award is to harness stem cells and synthetic gene circuits to repair glomerular injury and address the significant burden of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in the U.S. and worldwide. The research will leverage Duke's expertise in...

This $577,978 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support the "MOBILIZE: Mobility & Transportation Solutions to Improve Hemodialysis Access" research project at the University of California, Davis.

The project aims to: 1) Quantify social risk levels, including transportation insecurity, among 300 patients with end-stage kidney disease (ESKD) receiving in-center hemodialysis, and analyze associations with key health outcomes; 2) Evaluate the predictive validity of a novel Transportation Security Index (TSI) tool to identify patients at risk of missing dialysis appointments, compared to a standard transportation screening question; and 3) Conduct interviews to identify facilitators and barriers to home dialysis as a means of addressing transportation insecurity in the ESKD population. This research seeks to inform interventions that integrate social and medical care to improve health equity for patients with ESKD.

Generated 7/8/25, 1:29 PM